Russia to provide additional subsidies for development of generics of original foreign drugs

The Russian government will launch a project aimed at creating generic copies of patented original drugs, according to recent statements made by the deputy head of the Ministry of Industry and Trade, Ekaterina Priezzheva.

So far, competitive selections for the first list of drugs, consisting of 25 international non-proprietary names, took place at the end of December 2023. According to Ms Priezzheva, 30 competitions have already been completed. The winners of the contests will receive state subsidies, the amount of which will be in the range of 50–100 million roubles and even higher.

Under the terms of the project, the Russian drugmaker receives a subsidy for the development and registration of an analogue of patented foreign drugs.